Cameron Turtle Insider Trading for November 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Cameron Turtle.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Cameron Turtle for November 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 25 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Option Exercise | M | 17.00 | 742 | 12,614 | 263,000 | |
| Nov 25 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Option Exercise | M | 17.00 | 4,258 | 72,386 | 263,742 | |
| Nov 25 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Sell | S | 47.23 | 742 | 35,044 | 12,568 | 13.3 K to 12.6 K (-5.57 %) |
| Nov 25 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Buy | M | 17.00 | 742 | 12,614 | 13,310 | 12.6 K to 13.3 K (+5.90 %) |
| Nov 25 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Sell | S | 47.00 | 4,258 | 200,137 | 12,568 | 16.8 K to 12.6 K (-25.31 %) |
| Nov 25 2020 | BBIO | BridgeBio Pharma, ... | Turtle Cameron | See Remarks | Buy | M | 17.00 | 4,258 | 72,386 | 16,826 | 12.6 K to 16.8 K (+33.88 %) |
| Nov 13 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Gift | G | 0.00 | 1,500 | 0 | 50,621 | 52.1 K to 50.6 K (-2.88 %) |
| Nov 13 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 75.23 | 908 | 68,308 | 52,121 | 53 K to 52.1 K (-1.71 %) |
| Nov 13 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 74.75 | 9,497 | 709,860 | 53,029 | 62.5 K to 53 K (-15.19 %) |
| Nov 13 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 73.56 | 3,005 | 221,060 | 62,526 | 65.5 K to 62.5 K (-4.59 %) |
| Nov 03 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Option Exercise | M | 17.00 | 2,500 | 42,500 | 13,920 | |
| Nov 03 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Option Exercise | M | 13.20 | 5,000 | 66,000 | 75,000 | |
| Nov 03 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 72.10 | 209 | 15,068 | 65,531 | 65.7 K to 65.5 K (-0.32 %) |
| Nov 03 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 71.42 | 3,146 | 224,677 | 65,740 | 68.9 K to 65.7 K (-4.57 %) |
| Nov 03 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Sell | S | 70.44 | 9,145 | 644,209 | 68,886 | 78 K to 68.9 K (-11.72 %) |
| Nov 03 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Buy | M | 17.00 | 2,500 | 42,500 | 78,031 | 75.5 K to 78 K (+3.31 %) |
| Nov 03 2020 | EIDX | Eidos Therapeutics ... | Turtle Cameron | Chief Business Offi ... | Buy | M | 13.20 | 5,000 | 66,000 | 75,531 | 70.5 K to 75.5 K (+7.09 %) |